Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
WST
WST
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest WST ETF News Today | Earnings, Events & Price Alerts
WST News
West Pharmaceutical Services Announces Upcoming Investor Conferences
3d ago
PRnewswire
West Pharmaceutical Services Announces Upcoming Investor Conferences
4d ago
Newsfilter
Eli Lilly's Dominance in Obesity Drug Market Reinforced
Feb 23 2026
CNBC
West Pharmaceutical Services Authorizes $1B Share Repurchase Program
Feb 17 2026
seekingalpha
West Pharmaceutical Declares Quarterly Dividend and Share Repurchase Program
Feb 17 2026
Yahoo Finance
WEST PHARMACEUTICAL SERVICES INC: UBS LOWERS TARGET PRICE FROM $355 TO $340
Feb 13 2026
moomoo
West Pharmaceutical Services Reports Strong Q4 2025 Earnings and Positive Outlook
Feb 12 2026
seekingalpha
West Pharma (WST) Q4 2025 Earnings Call Transcript
Feb 12 2026
NASDAQ.COM
WEST PHARMACEUTICAL SERVICES STOCK RISES 2.8% FOLLOWING POSITIVE 2026 PROFIT OUTLOOK
Feb 12 2026
moomoo
West Pharma Executive Reports Steady Customer Behavior and Calls Annual Forecast a Conservative Beginning - Conference Call
Feb 12 2026
moomoo
West Pharma Executive Anticipates GLP-1 Demand Growth in 2026, but Slower than 2025 - Conference Call Insights
Feb 12 2026
moomoo
West Pharma Executive Anticipates Growth in Injectable and Oral GLP-1 Products by 2026 - Conference Call
Feb 12 2026
moomoo
West Pharmaceutical Stock Rises 4.5% in Premarket Trading Following 2026 Profit Forecast Exceeding Expectations
Feb 12 2026
moomoo
S&P 500 Futures Rise in Pre-Market Trading; Icon PLC and Baxter International Underperform
Feb 12 2026
Barron's
West Pharmaceutical Services Reports Strong Q4 2025 Results and Guidance
Feb 12 2026
PRnewswire
West Pharmaceutical Releases 2026 Financial Outlook
Feb 12 2026
seekingalpha
Show More News
